Tumor cell-intrinsic expression of immune checkpoint molecules revealed by RNA in situ hybridization

被引:0
|
作者
Harms, U. [1 ]
Li, N. [1 ]
Rouault, M. [1 ]
Wilkens, K. [1 ]
Ma, X-J. [1 ]
Park, E. [1 ]
机构
[1] Adv Cell Diagnost, Segrate, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
70
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Mechanisms of Tumor Cell-Intrinsic Immune Evasion
    Spranger, Stefani
    Gajewski, Thomas F.
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 2, 2018, 2 : 213 - 228
  • [2] Characterization of immune checkpoint marker expression and infiltrating lymphoid and myeloid immune cells in the tumor microenvironment by RNA in situ hybridization
    Laeremans, Annelies
    Li, Na
    Kim, Jeffrey
    Ma, Xiao-Jun
    Park, Emily
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] Targeting mesenchymal tumor cell-intrinsic factors sensitizes refractory tumors to immune checkpoint blockade therapy
    Bakhle, Kimaya M.
    Sams, Caitie H.
    Dongre, Anushka
    CANCER RESEARCH, 2024, 84 (06)
  • [4] Multifaceted roles of PD-1 in tumorigenesis: From immune checkpoint to tumor cell-intrinsic function
    Chen, Huiqing
    Wei, Jiayu
    Zhu, Zhen
    Hou, Yongzhong
    MOLECULAR CARCINOGENESIS, 2024, 63 (08) : 1436 - 1448
  • [5] Extrinsic and Cell-Intrinsic Stress in the Immune Tumor Micro-Environment
    Ummarino, Aldo
    Cala, Nicholas
    Allavena, Paola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [6] A Tumor Cell-Intrinsic Yin-Yang Determining Immune Evasion
    Horton, Brendan
    Spranger, Stefani
    IMMUNITY, 2018, 49 (01) : 11 - 13
  • [7] Tumor Cell-intrinsic Activation of the Immune Receptor RIG-I in Combination with Immune Checkpoint Blockade improves anti-Tumor T-Cell Responses
    Thier, B.
    Such, L.
    Sucker, A.
    Coch, C.
    Hartmann, G.
    Schadendorf, D.
    Griewank, K.
    Trilling, M.
    Zhao, F.
    Paschen, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 10 - 10
  • [8] Tumor cell-intrinsic activity of the RNA receptor RIG-I promotes checkpoint inhibitor-mediated anticancer immunity
    Heidegger, S.
    Wintges, A.
    Stritzke, F.
    Bek, S.
    Steiger, K.
    Winter, C.
    Rad, R.
    van den Brink, M. R. M.
    Ruland, J.
    Bassermann, F.
    Chan, T.
    Haas, T.
    Poeck, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 247 - 247
  • [9] Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
    Li, Jinyang
    Byme, Katelyn T.
    Yan, Fangxue
    Yamazoe, Taiji
    Chen, Zeyu
    Baslan, Timour
    Richman, Lee P.
    Lin, Jeffrey H.
    Sun, Yu H.
    Rech, Andrew J.
    Balli, David
    Hay, Ceire A.
    Sela, Yogev
    Merrell, Allyson J.
    Liudahl, Shannon M.
    Gordon, Naomi
    Norgard, Robert J.
    Yuan, Salina
    Yu, Sixiang
    Chao, Timothy
    Ye, Shuai
    Eisinger-Mathason, T. S. Karin
    Faryabi, Robert B.
    Tobias, John W.
    Lowe, Scott W.
    Coussens, Lisa M.
    Wherry, E. John
    Vonderheide, Robert H.
    Stangert, Ben Z.
    IMMUNITY, 2018, 49 (01) : 178 - +
  • [10] Elevated Tumor Cell-Intrinsic STING Expression in Advanced Laryngeal Cancer
    Viculin, Jelena
    Degoricija, Marina
    Vilovic, Katarina
    Gabela, Ivana
    Frankovic, Lucija
    Vrdoljak, Eduard
    Korac-Prlic, Jelena
    CANCERS, 2023, 15 (13)